Wordt geladen...

Bayesian designs of phase II oncology trials to select maximum effective dose assuming monotonic dose-response relationship

BACKGROUND: For many molecularly targeted agents, the probability of response may be assumed to either increase or increase and then plateau in the tested dose range. Therefore, identifying the maximum effective dose, defined as the lowest dose that achieves a pre-specified target response and beyon...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Guo, Beibei, Li, Yisheng
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: BioMed Central 2014
Onderwerpen:
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4119476/
https://ncbi.nlm.nih.gov/pubmed/25074481
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2288-14-95
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!